Hemovigilance: An Effective Tool for Improving Transfusion Safety

Professor Rene R.P. De Vries, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands and President of the European Haemovigilance Network. Dr Jean Claude Faber, Director of the Blood Transfusion Service, Luxembourg Red Cross, Luxembourg. The editors are experts in the field of haemovigilance. Both are members of the Board of the International Haemovigilance Network (IHN) and of the International Society of Blood Transfusion (ISBT) Working Party on Haemovigilance.

List of Contributors, viii Foreword, xii Part 1 General Introduction 1 Introduction, 3 Ren'e R.P. de Vries 2 Hemovigilance: A Quality Tool for the Blood Transfusion Chain, 5 Ren'e R.P. de Vries 3 Concepts and Models, 12 Ren'e R.P. de Vries and Jean-Claude Faber Part 2 Hemovigilance of the Blood Transfusion Chain (Blood Establishment and Hospital) Section 2.1: Setting up a Hemovigilance System 4 Setting Up or Consolidating a System for Donor Hemovigilance at the Level of a Blood Establishment, 21 Johanna Wiersum-Osselton, Wim de Kort, Tanneke Marijt-van der Kreek, and Jeroen de Wit 5 Preparation of Blood Components, 36 Tomislav Vuk 6 Establishment of Hemovigilance for the Testing, Storage, Distribution, Transport, and Issuing of Blood and Blood Components: The Example of Greece, 52 Constantina Politis 7 Medical Decision, Ordering, Administration of Component, and Monitoring of the Patient, 61 Mickey B.C. Koh, Ramir Alcantara, Mark Grumbridge, and Ai Leen Ang Section 2.2: How the System Works 8 Blood Donation: An Approach to Donor Vigilance, 77 Peter Tomasulo, Madhav Erraguntla, and Hany Kamel 9 Preparation of Blood Components, 99 Erhard Seifried, Reinhard Henschler, Juergen Luhm, Thea Mueller-Kuller, Hans-Ulrich Pfeiffer, Walid Sireis, and Markus M. Mueller 10 Testing, Issuing, and Transport of Blood Components, 113 Constantina Politis 11 Clinical Activities: Medical Decision-making, Sampling, Ordering Components, Administration, and Patient Monitoring, 126 Clare Taylor Part 3 National or Regional Hemovigilance Systems 12 The French Hemovigilance Network: From the Blood Scandal to Epidemiologic Surveillance of the Transfusion Chain, 147 Philippe Renaudier 13 The Japanese Hemovigilance System, 159 Hitoshi Okazaki, Naoko Goto, Shun-ya Momose, Satoru Hino, and Kenji Tadokoro 14 Setting up a National Hemovigilance System: SHOT, 168 Hannah Cohen and Lorna M. Williamson 15 The Dutch Hemovigilance System: Transfusion Reactions in Patients (TRIP), 180 Martin R. Schipperus, Johanna Wiersum-Osselton, Pauline Y. Zijlker-Jansen, and Anita J.W. van Tilborgh-de Jong 16 Regulatory, Public Health, and International Aspects of Hemovigilance in Canada, 191 Peter R. Ganz and Jun Wu 17 Setting up and Implementation of the National Hemovigilance System in Italy, 204 Giuliano Grazzini and Simonetta Pupella 18 The Australian Hemovigilance System, 209 Erica M. Wood, Lisa J. Stevenson, Simon A. Brown, and Christopher J. Hogan 19 Biovigilance in the United States, 220 D. Michael Strong, Barbee Whitaker, Matthew J. Kuehnert, and Jerry A. Holmberg 20 Arab Hemovigilance Network, 226 Salwa Hindawi, Magdy Elekiaby, and Gamal Gabra Part 4 Hemovigilance at the International Level 21 Hemovigilance in the European Community, 235 Jean-Claude Faber 22 International collaboration, 253 Paul F.W. Strengers 23 Hemovigilance in Developing Countries, 260 Jean-Claude Faber Part 5 Achievements 24 Achievements Through Hemovigilance, 281 Jean-Claude Faber and F'atima Nascimento Part 6 Developments 25 Vigilance of Alternatives for Blood Components, 305 Dafydd Thomas 26 Surveillance of Clinical Effectiveness of Transfusion, 322 Brian McClelland and Katherine Forrester 27 Biovigilance, 326 Jerry A. Holmberg, Matthew J. Kuehnert, and D. Michael Strong Appendices Appendix A Glossary, 343 Appendix B Proposed standard definitions for surveillance of non infectious adverse transfusion reactions, 351 Appendix C Standard for surveillance of complications related to blood donation, 360 Index, 369